Corcept Therapeutics
CORT
#2848
Rank
HK$46.33 B
Marketcap
HK$431.64
Share price
-2.22%
Change (1 day)
-26.24%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): HK$55.71 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are HK$0.76 Billion. In 2025 the company made an earning of HK$0.52 Billion a decrease over its 2024 earnings that were of HK$1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$55.71 M-89.3%
2025 HK$0.52 B-58.84%
2024 HK$1.26 B29.65%
2023 HK$0.97 B7.2%
2022 HK$0.90 B-7.05%
2021 HK$0.97 B-5.01%
2020 HK$1.03 B12.79%
2019 HK$0.91 B26.61%
2018 HK$0.72 B74.51%
2017 HK$0.41 B548.72%
2016 HK$63.74 M-227.03%
2015 -HK$50.19 Million-79.58%
2014 -HK$0.25 Billion-31.79%
2013 -HK$0.37 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.44 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.60 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$82.93 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.73 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$102.99 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.15 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$11.01 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.22 Billion-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.01 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA